FDA & Regulatory
Supplemental New Drug Application
A supplemental New Drug Application (sNDA) seeks FDA approval to change an already-approved drug — most often to add a new indication, dosage, or label expansion. Approvals can unlock additional addressable markets for a marketed product.
- Category
- FDA & Regulatory
- Abbreviation
- sNDA
Prepared research question
How does Supplemental New Drug Application affect the view of a biotech company in practice?
Traceable citations · Unknowns marked
A supplemental New Drug Application (sNDA) seeks FDA approval to change an already-approved drug — most often to add a new indication, dosage, or label expansion. Approvals can unlock additional addressable markets for a marketed product.
Related terms
From term to thesis rule
Investigate how Supplemental New Drug Application changes a biotech thesis
Define when Supplemental New Drug Application should count, block, or trigger a deeper check; BioSniper will compile that logic against available evidence.